Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.64 +0.07 (+0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Selling, General & Administrative (2019 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) recorded Selling, General & Administrative of $28.05 million in Q2 2026, down 17.3% from $33.92 million a year earlier and down 13.7% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Selling, General & Administrative (2019 - 2026) Analysis & Trends

On a TTM basis, Harmony Biosciences Holdings' Selling, General & Administrative came in at $147.93 million as of Jun 30, 2026, up 20.6% year-over-year; for FY2025, it was $152.54 million, up 38.2% from FY2024.

  • Annual Selling, General & Administrative has increased for six straight years, with a five-year compound annual growth rate of 30.9% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $110.35 million in FY2024 (+15.8%), $95.29 million in FY2023 (+13.4%), $84.02 million in FY2022 (+31.5%) and $63.91 million in FY2021 (+60.8%).
  • The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q2 2024.
  • On a year-over-year basis, Selling, General & Administrative rose in seven of the last eight quarters, with growth averaging 20.9%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 99.4% in Q4 2025, against a decline of 17.3% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $32.51 million (Q1 2026), $57.56 million (Q4 2025) and $29.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Harmony Biosciences Holdings 2.30 Bn -452.73 Mn 198.08 Mn 28.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.05 Mn
Mar 31, 2026 32.51 Mn
Dec 31, 2025 57.56 Mn
Sep 30, 2025 29.81 Mn
Jun 30, 2025 33.92 Mn
Mar 31, 2025 31.24 Mn
Dec 31, 2024 28.87 Mn
Sep 30, 2024 28.59 Mn
Jun 30, 2024 27.22 Mn
Mar 31, 2024 25.68 Mn
Dec 31, 2023 27.87 Mn
Sep 30, 2023 22.55 Mn
Jun 30, 2023 22.81 Mn
Mar 31, 2023 22.06 Mn
Dec 31, 2022 22.64 Mn
Sep 30, 2022 21.33 Mn
Jun 30, 2022 22.16 Mn
Mar 31, 2022 17.88 Mn
Dec 31, 2021 18.21 Mn
Sep 30, 2021 16.86 Mn
API Access

Harmony Biosciences Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HRMY&period=max&api_key=YOUR_API_KEY